Here are relevant reports on : analytical-standards-market
-
Chiral Chromatography Column Market by Technology (GC, LC, TLC, Flash Chromatography), Type (Empty, Prepacked, Analytical, Preparative), Material (Metal, Glass, Plastic), End User (Hospital, Food, Pharma-Biotech, Environmental) & Region - Global Forecasts to 2025
The global chiral chromatography column market growth is primed to transition from $99 million in 2020 to $123 million by 2025, showcasing a strong CAGR of 4.5%. Market growth is driven largely by factors, such as increasing R&D investments in the pharmaceutical and biotechnology industry, and increasing importance of chromatography tests for drug approvals. Moreover, growth opportunities in emerging countries as well as green chromatography are expected to present avenues of growth for market players.
- Published: December 2020
- Price: $ 4950
- TOC Available:
-
Healthcare Analytical Testing Services Market by Testing Type (Cell-based, Bioanalytical, Raw Material, Microbial, Stability, Batch-release, Genomic, Method Development & Validation), End User (Pharma, MedTech, Hospital), Region - Global Forecast to 2030
The global healthcare analytical testing services market, valued at US$6.33 billion in 2023, stood at US$7.48 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a forecasted valuation of US$12.48 billion by the end of the period. The key factors contributing to market growth include stringent regulatory guidelines, a growing focus on analytical testing of biologics and biosimilars, increasing outsourcing of analytical testing by pharmaceutical and medical device companies, and the rising acceptance of a quality-by-design approach in pharmaceutical research and manufacturing.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Peptide Synthesis Market by Instruments (Synthesizers, Purification, Lyophilizers, Analytical), Reagents (Amino Acids, Resins), Technique (Chemical, Biological), Services (Custom Synthesis, Modification), Application, End User - Global Forecast to 2031
The global peptide synthesis market is projected to reach USD 1.54 billion by 2031, growing at a CAGR of 9.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: August 2026
- Price: $ 4950
- TOC Available:
-
Drug Screening Market by Offering [On-site Testing, Rapid Testing (Urine, Oral), Analytical (Breathalyzer, Immunoassay, Chromatography)], Sample (Blood, Urine, Hair), Drug (Cannabis, Alcohol), End User (Workplace, Law, Hospitals) - Global Forecast to 2030
The global drug screening market, valued at US$8.92 billion in 2024, stood at US$10.36 billion in 2025 and is projected to advance at a resilient CAGR of 15.5% from 2025 to 2030, culminating in a forecasted valuation of US$21.29 billion by the end of the period. The market for drug screening is being fueled by growing workplace and clinical testing programs, an increased need for opioid/polysubstance monitoring, and an increased use of rapid point-of-care technologies and advanced confirmatory testing (LC MS/MS) systems.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
Clinical Manufacturing Services Market by Finished Dosage Formulations (Tablets, Capsules, Oral Dosages), Type (Analytical Services, Formulation Development, Stability/Storage), End-User (Pharmaceuticals Biopharmaceuticals) - Global Forecast to 2023
In the face of limited resources, the pharmaceutical companies have been recently focusing on the areas of their core competency in drug research and development. The capital-intensive nature of pharmaceutical drug R&D activities have created a need to outsource clinical stage manufacturing of drugs. Clinical manufacturing services include development of formulations for clinical trials, analysis of those formulations and their solubility and stability testing services.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Biopharmaceutical Process Analytical Technology Market by Modality (Spectroscopy: Raman, IR, NMR; Chromatography: HPLC, GC; MS, qPCR, NGS), Product (Analyzer, Sensor, Software), Mode (Online, At-line), Application (Biologics, CGT)- Global Forecast to 2031
The global biopharmaceutical process analytical technology market is projected to reach USD 4.32 billion by 2031, growing at a CAGR of 17.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Analytical Laboratory Services Market by Public Health Organization, - by types of services (Stability, Raw Material, Physical Characterization, Method Validation, Microbial Testing, Environmental Monitoring, Bioanalytical Testing) - Global Forecast to 2022
The global analytical laboratory services market, by public health organization is projected to reach USD 333.8 Million by 2021 from USD 202.8 Million in 2016, at a CAGR of around 10.5% during the forecast period. The overall analytical laboratory services market, by public health organization is positively impacted by factors such as the growing expenditure on drugs and medical devices by public health organizations, government initiatives to strengthen analytical testing capabilities, increasing number of drug approvals & clinical trials, and rising demand for specialized analytical testing services.
- Published: April 2017
- Price: $ 4950
- TOC Available:
-
Neural Network Software Market by Type (Data Mining and Archiving, Analytical Software, Optimization Software, and Visualization Software), Vertical, and Region - Global Forecast to 2021
MarketsandMarkets forecasts the neural network software market size to grow from USD 7.17 Billion in 2016 to USD 22.55 Billion by 2021, at an estimated Compound Annual Growth Rate (CAGR) of 33.2%. Major factors contributing to the growth of the neural network software market are increasing amount of spatial data and rising demand for predictive solutions.
- Published: January 2017
- Price: $ 4950
- TOC Available:
-
Track Etched Membrane Market by Product (Membrane Filter, Capsule & Cartridge Filter, Cell Culture Insert), Material (Polycarbonate, Polyimide), Application (Cell Biology, Microbiology, Analytical testing, Automotive), End User - Global Forecasts to 2023
The track etched membrane market is projected to reach USD 813.1 million by 2023, growing at a CAGR of 11.3%. Key players operating in the global track etched membrane are GE Healthcare (US), Danaher (US), Corning (US), Merck (Germany), it4ip (Belgium), Sterlitech (US), Oxyphen (Switzerland), Sarstedt (US), BRAND GMBH (Germany), Sartorius (Germany), SABEU (Germany), Zefon International (US), GVS (Italy), Thermo Fisher Scientific (US), Eaton (Ireland), Greiner Bio-One (Austria), MACHEREY-NAGEL (Germany), Avanti Lipids Polar (US), SKC (US), Advantec (Canada), Avestin (Canada), Scaffdex (Finland), and Graver Technologies (US).
- Published: September 2018
- Price: $ 4950
- TOC Available:
-
Agricultural Biologicals Testing Market by Product Type (Biopesticides, Biofertilizers, Biostimulants), Application (Field Support, Analytical, Regulatory), End User, and Region - Global Forecast to 2021
The agricultural biologicals testing market is projected to grow at a CAGR of 10.4% from 2016 to reach USD 1.12 Billion by 2021. The base year considered for the study is 2015 and the forecast years are from 2016 to 2021. The objectives of the report are to project the market size, by product type, application, end user, and region in terms of value and to strategically profile key players and comprehensively analyze their market share, and core competencies. The agricultural biologicals testing market is segmented on the basis of application including field support, analytical, and regulatory. It is also segmented on the basis of region into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
- Published: September 2016
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
